GZMB and COVID-19: Assessing the phenotypical profile of SARS-CoV-2–specific CD4+ T cells, the following trends were observed in less severe forms of COVID-19 (WHO 4 or lower): increased expression of CD38, Ki67, and GrB and reduced expression of HLA-DR.